aNP-TRAP: a conceptual platform for in situ microbial cultivation and functional detection of antimicrobial activity

Microbial natural products are central to drug discovery, yet many biosynthetic gene clusters remain transcriptionally silent under standard laboratory conditions. Conventional screening workflows—based on ex situ cultivation and metabolite extraction—can be labor-intensive and often fail to capture ecologically relevant microbial interactions. To address these limitations, we propose the aNP-TRAP (Activity-guided Natural Product Triaging and Recognition Assay Platform), a conceptual, field-deployable device designed to integrate in situ microbial cultivation with functional detection of bioactivity. The system consists of a honeycomb array of cultivation wells, semipermeable and gradient membranes to permit directional metabolite diffusion, and a detection layer containing biosensors responsive to antibacterial, antifungal, or quorum-sensing–inhibitory compounds. Three detection strategies are envisioned: Escherichia coli JW5503-1 with resazurin for antibacterial activity, Candida albicans for antifungal screening, and Chromobacterium violaceum CV026 for quorum-sensing inhibition. Microbial metabolites diffusing through the membranes interact with the biosensor matrices, potentially generating colorimetric or pigment-based signals. This platform is conceptual and currently lacks empirical validation; all performance expectations derive from simulation-based reasoning. In brief, simulations suggested a 0.2 µm membrane equilibrates nutrients within ∼2–6 h, directional metabolite flux achieves >95% reflux suppression within ∼6–10 h, and biosensor responses become detectable within ∼4–10 h at representative inhibitory ranges. Although unvalidated, this integrated configuration may support early-stage triaging of microbial isolates and help guide the discovery of bioactive compounds from under-explored microbial communities. The platform should be viewed as a hypothesis-generating concept rather than a validated tool.

Authors

Institutions

Publication Details

Journal
Frontiers in Natural Products
Published
2025-09-04
DOI
https://doi.org/10.3389/fntpr.2025.1617079
Citations
2
Primary Topic
Microbial Natural Products and Biosynthesis
Type
article
Field-Weighted Citation Impact
2.79
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

aNP-TRAP: a conceptual platform for in situ microbial cultivation and functional detection of antimicrobial activity

Maxwel Adriano Abegg
2 citations
Frontiers in Natural Products
Microbial Natural Products and Biosynthesis
2.79
article

aNP-TRAP: a conceptual platform for in situ microbial cultivation and functional detection of antimicrobial activity

Maxwel Adriano Abegg
article en
2 citations

Abstract

Microbial natural products are central to drug discovery, yet many biosynthetic gene clusters remain transcriptionally silent under standard laboratory conditions. Conventional screening workflows—based on ex situ cultivation and metabolite extraction—can be labor-intensive and often fail to capture ecologically relevant microbial interactions. To address these limitations, we propose the aNP-TRAP (Activity-guided Natural Product Triaging and Recognition Assay Platform), a conceptual, field-deployable device designed to integrate in situ microbial cultivation with functional detection of bioactivity. The system consists of a honeycomb array of cultivation wells, semipermeable and gradient membranes to permit directional metabolite diffusion, and a detection layer containing biosensors responsive to antibacterial, antifungal, or quorum-sensing–inhibitory compounds. Three detection strategies are envisioned: Escherichia coli JW5503-1 with resazurin for antibacterial activity, Candida albicans for antifungal screening, and Chromobacterium violaceum CV026 for quorum-sensing inhibition. Microbial metabolites diffusing through the membranes interact with the biosensor matrices, potentially generating colorimetric or pigment-based signals. This platform is conceptual and currently lacks empirical validation; all performance expectations derive from simulation-based reasoning. In brief, simulations suggested a 0.2 µm membrane equilibrates nutrients within ∼2–6 h, directional metabolite flux achieves >95% reflux suppression within ∼6–10 h, and biosensor responses become detectable within ∼4–10 h at representative inhibitory ranges. Although unvalidated, this integrated configuration may support early-stage triaging of microbial isolates and help guide the discovery of bioactive compounds from under-explored microbial communities. The platform should be viewed as a hypothesis-generating concept rather than a validated tool.

Frontiers in Natural ProductsVol. 4
Universidade Federal do Amazonas (BR)
Openalex Percentile: Top 9%
Microbial Natural Products and Biosynthesis
2.79
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

aNP-TRAP: a conceptual platform for in situ microbial cultivation and functional detection of antimicrobial activity — Maxwel Adriano Abegg · Frontiers in Natural Products (2025) | TGRS Research Map | TGRS